Junior and Teen Play Equipment

Surlingham Parish Council conducted a public consultation in April 2026 to gather views on the condition and future development of Surlingham Play Area. The consultation was promoted through multiple village channels and received responses from 21 households, plus two child friendly questionnaires via Surlingham School. Although participation was modest, the feedback provides clear and consistent direction for refurbishment priorities. The findings highlight concerns around safety, accessibility, equipment suitability, and the overall quality of the play environment.

Tullie House Museum and Art Gallery Trust (the Trust) in Carlisle (brand name: Tullie) is seeking an experienced Digital Installation Designer to plan and deliver an immersive digital space within a new 'Active Gallery', as part of Project Tullie Phase 3: Breaking Down Barriers. We're looking for an individual or organisation to deliver a 360-degree 'Immersive Art' experience. Six paintings from Tullie's fine art collection should each be brought to life through digital projection and interpretation, which may incorporate animation, cinemagraphs, soundscapes, and interactive elements. The services must include expertise both in software and hardware design and the appointed professional must be able to take the concept through to full delivery within the timeframes stated. Details can be found at: https://tullie.org.uk/project-tullie-phase-3-fine-art-digital-installation-design-rfq/

Play tower with slide Fall mitigation area https://www.quornparishcouncil.gov.uk/news/announcements/ YOUR MUST SUBMIT YOUR TENDER IN WRITING TO THE ADDRESS SHOWN AT THE BOTTOM OF THE TENDER Additional information: Please see below our responses to points raised: • Project Budget: There is no fixed budget for the project. We will be applying for S106 funding based on the winning tender submission. • Tender Deadline: The deadline for submissions is 7 October at 9:00am. Yes, this is correct. • Tender Submission: The tender must be submitted in physical/postal format only to: The Parish Manager Quorn Parish Council The Old School School Lane Quorn Leicestershire LE12 8BL The outside of the envelope/postal tube should be clearly marked: 'PLAY TOWER TENDER ENCLOSED'. Yes, this is correct. • 2D/3D Visualisation Plans: There are no restrictions regarding the quantity, format or content of the 2D/3D visualisation plans submitted. Company branding may also be included at a minimal level. • Multiplay Unit Platform Heights: The stated 2.4m height is intended to indicate the age range associated with the equipment. Proposals incorporating slightly different platform heights may therefore be considered, where appropriate, to ensure the equipment is suitable for the intended age range. • Materials - Robinia and Stainless Steel: Robinia and stainless steel have been provided as examples of materials associated with longevity and durability. These specifications are not restrictive. Alternative materials, including hot-dip galvanised and powder-coated steel construction, will be considered, provided the proposed materials can demonstrate comparable longevity and durability in accordance with the tender scoring criteria. • It is not necessary to provide 3D visuals as 2D drawing will be acceptable

Competent consultancy companies are hereby invited to tender to design, develop and deliver a structured PEACEPLUS programme celebrating Holi - the Hindu Festival of colours. The project will include a programme of interactive workshops and celebration activities and will be delivered in partnership with the Indian community in Crotlieve DEA. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18477. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18477 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Competent consultancy organisations are invited to tender for the design and delivery of a culturally focused integration programme for Key Stage 3 pupils in the Slieve Croob DEA. This initiative will bring together young people from diverse cultural backgrounds, including those from minority ethnic communities, to promote inclusion, intercultural understanding and positive relationships. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18415. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18415 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

NHS Essex Integrated Care Board is undertaking a Competitive Process under the Health Care Services (Provider Selection Regime) Regulations 2023 for the award of a General Medical Services (GMS) contract for Tollgate Practice, Stanway, Colchester. The Authority seeks a suitably qualified provider to deliver primary medical services to a registered patient population of approximately 10,206 patients. Services will be provided under a nationally prescribed GMS contract from the existing practice premises and will include the delivery of core primary medical services, management of the registered patient list, clinical governance, safeguarding, information governance and integration with local health and care services. This procurement is being undertaken to secure the long-term provision of stable, resilient and high-quality primary medical services for the local population. Due to the fixed practice location, established patient list and requirement for uninterrupted service delivery, bidders must demonstrate the ability to mobilise and maintain an appropriately qualified workforce and robust governance arrangements from contract commencement. The contract will be awarded following evaluation against the key criteria set out in the Health Care Services (Provider Selection Regime) Regulations 2023. The estimated contract value is £21,896,491.60, calculated using a notional 20-year term for valuation purposes only. The contract itself is a perpetual GMS contract and is not time limited. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,

The American Institute in Taiwan Public Diplomacy Section announces an open competition for one cooperative agreement to support the implementation of four Global Cooperation and Training Framework Classic workshops in Taiwan during calendar year 2027. The GCTF is a capacity building platform that brings together government officials, industry experts, academics, and civil society representatives to exchange practical experience and promote professional cooperation on emerging regional and global challenges. Workshop topics will be jointly identified by GCTF partners and may address resilience, emerging technologies, economic security, trusted supply chains, democratic governance, and other shared priorities. The selected recipient will serve as the implementation partner responsible for comprehensive operational and administrative support, including venue coordination, participant registration, international travel support, interpretation, audiovisual services, workshop materials, vendor coordination, site visits, monitoring and evaluation, and required grant reporting. Most workshops are expected to take place in Taipei, with one anticipated in southern Taiwan. AIT and GCTF partners will provide policy guidance, strategic direction, and substantive oversight. The project is intended to strengthen international cooperation, promote policy dialogue and capacity building, improve continuity across GCTF programming, and advance practical exchanges among government, industry, academia, and civil society.

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this NOFO are expected to propose a multisite feasibility clinical trial that will provide new information that is scientifically necessary for the planning and conduct of a subsequent clinical efficacy or effectiveness study, pragmatic trial, or dissemination and implementation trial within NCCIHs mission. NCCIH expects that applications to this NOFO will describe the planned future clinical trial and in so doing demonstrate that the proposed (R01) research is scientifically necessary to design or plan the subsequent fully powered, full-scale clinical trial. Under this R01, the data collected should be used to fill gaps in scientific knowledge, including, but not limited to the following: assessing whether the intervention can be delivered with fidelity across sites; demonstrating feasibility of recruitment, accrual, and randomization of participants across sites; demonstrating participant adherence to the intervention, as well as retention of participants throughout the study across sites; refining and assessing the feasibility of protocolized multimodal interventions, and/or demonstrating feasibility of data collection across sites in preparation for a future fully powered, multisite efficacy or effectiveness trial. The need for multisite feasibility trials is expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s) or the published literature. The data collected should be used to fill gaps in scientific knowledge and be necessary to develop a competitive fully powered multisite clinical trial that has the potential to make a significant impact on public health.